Chesapeake PERL Inc.
This article was originally published in Start Up
Executive Summary
Cell culture is the widely accepted and proven methodology for manufacturing recombinant proteins but it can be costly, time-consuming, and inflexible. Chesapeake PERL Inc. (C-PERL)--short for protein expression and recovery labs--is hoping to change this: its mission is to manufacture proteins inexpensively and quickly so it can serve as a contract manufacturer for biopharmaceuticals, especially small-to-midsize firms that require the flexibility of swiftly switching between producing quantities of protein A to protein B.